In this second of a four-part podcast series on the science, regulatory framework, commercial transactions, and privacy and data security considerations of each unique aspect of the current health crisis, Michael Ward, MoFo partner and global head of the firm’s Life Sciences Group and Patent Group, discusses the issues, among other topics, with:
- Jean Nguyen, patent associate, founder and co-leader of the firm’s Life Sciences Data Analytics patent group: How are companies using AI and machine learning to combat the coronavirus? Can this technology predict who is at risk? How might this technology be helpful in predicting how COVID-19 or any other virus is spreading?
- Kristen Mathews, partner in MoFo’s Global Privacy + Data Security practice: What are privacy issues involved with contact tracing? Who has access to this data? What kind of government guidelines are being put in place regarding how the data is collected?
- Matt Karlyn, partner in MoFo’s Commercial Life Sciences Transactions + Licensing Group and in the firm’s Technology Transactions practice: What developments have you seen with regard to cloud computing and AI? How are companies collaborating to use this data in the fight against COVID-19? What are some of the legal issues companies should be aware of when negotiating deals involving data and AI?
- Bethany Hills, partner and head of MoFo’s FDA Regulatory + Life Sciences Compliance practice: What are some of the ways the FDA is addressing the use of AI and software in fighting COVID-19? Is the software critical to new ways of providing care during the pandemic? Any other firsts for the FDA in recent months?
A former lead engineer at the NASA Jet Propulsion Laboratory, Dr. Nguyen focuses her practice on domestic and international patent prosecution. She is a founder and co-leader of the firm’s Life Sciences Data Analytics patent group. She applies her experience also from her doctoral studies and her work as a former research scholar to provide portfolio management and counseling, IP due diligence, and freedom-to-operate More ›
Kristen J. Mathews
Kristen is a partner in our Global Privacy + Data Security Group. For more than 20 years, Kristen’s practice has focused on advising clients on the full spectrum of the most complex privacy and cybersecurity issues, including regulatory and compliance matters. An early leader in the privacy sphere, Kristen has developed comprehensive knowledge and long-term perspective, cultivated a client base across a broad range More ›
Matthew A. Karlyn has 23 years of experience in working with companies in the healthcare, pharmaceutical, medical device, and technology industries on a wide range of commercial life sciences, licensing, and technology transactions. His clients range from Fortune 100 companies to start-ups, and he regularly advises companies on matters involving IP commercialization, complex collaboration transactions, licensing initiatives, subscription-based economics, and business transactions related to More ›
Bethany J. Hills
Bethany advises her life sciences business clients on both pre- and post-market issues, including everything from FDA submissions and communications strategies to post-approval compliance and reimbursement issues. Her clients include medical device, drug, combination product, diagnostic, biologic, and regenerative medicine, cosmetic, dietary supplement, and food industry companies, and the investor groups focusing on these industries.
Bethany leverages her deep FDA regulatory experience and exceptional knowledge More ›
Michael R. Ward
Michael R. Ward is global head of the firm’s Life Sciences Practice Group, head of the firm’s Patent Practice Group, co-chair of the firm’s Intellectual Property Practice Group and co-chair of our global AgTech + Food Industry practice.
Dr. Ward is widely recognized as one of the world’s leading agriculture IP lawyers. As the founder and head of the firm’s Plant Intellectual Property Group, Dr. More ›